Search results for "CRISPR"

showing 10 items of 68 documents

Citrus biotechnology

2020

Agricultural crops that can better withstand the changing climatic and pathogen landscape have been produced through natural selection throughout the millennia and, in recent years, through the process of human-assisted plant breeding and selection. However, a lack of genetic diversity in many commercially cultivated crops (due to monoculture) has made them more vulnerable to biotic and abiotic stresses (Esquinas-Alcazar, 2005; Keneni et al., 2012). Citrus, belonging to the Rutaceae family, is one of the most important commercial woody fruit crops in the tropical and subtropical areas of the world. The origin of citrus is traced back to parts of tropical and subtropical Southeast Asia (Wu e…

Settore AGR/03 - Arboricoltura Generale E Coltivazioni ArboreeMicropropagation Organogenesis and rooting Gametic embryogenesisSomaclonal variation Allotetraploids via somatic hybridization Somatic cybridization Molecular marker development for Alternaria brown spot disease Reducing juvenility via viral vectors Genetic transformation of citrus Direct DNA incorporation into citrus Protoplast transformation Particle bombardment/biolistics Agrobacterium-mediated transformation of citrus CRISPR gene editing
researchProduct

Chi dice che i batteri fanno male? I CRISPR ed il loro potenziale genetico. In Le scienze naturali nella scuola

2019

L’immaginario collettivo non ha un’opinione buona e nemmeno benevola sui batteri. Sono spesso legati a concetti di mancanza di igiene, malattie ed a volte anche a situazioni più gravi financo la morte. È indubbio che alcuni generi di procarioti sono agenti patogeni di specifiche malattie infettive che, in passato più che oggi, hanno mietuto vittime nel genere umano. Ma che dire dei batteri lattici degli yogurt o della nostra flora batterica intestinale? C’è da aggiungere anche una lunga serie di organismi procarioti, non patogeni, che hanno, negli ultimi due secoli, costituito sistemi biologici idonei allo studio della biologia molecolare e della genetica molecolare. In definitiva è molto p…

Settore BIO/18 - GeneticaCRISPR-Cas9 batteri bioetica
researchProduct

Investigating CRISPR-CAS13b as a tool for the RNA editing of CFTR mRNA with premature stop codon

2020

Background and Rationale Some CF patients are compound heterozygous or homozygous for nonsense mutations in the CFTR gene. Mutant CFTR gene coding for transcripts with premature termination codons (PTCs) is responsible for truncated CFTR protein and for a severe form of the disease. In a precision medicine framework the “REPAIRv2” (RNA Editing for Programmable A to I Replacement v2) tool, developed in the laboratory of Dr. Feng Zhang (USA), seems a good alternative to restore the full-length CFTR protein by editing its mRNA containing PTCs. This new approach is based on the possibility of targeting a deaminase enzyme (huADAR2) to a specific Adenosine, to be edited to Inosine (G analogue), o…

Settore BIO/18 - GeneticamRNA editing CFTR CRISPR-dCAS13b
researchProduct

The high-performance technology CRISPR/Cas9 improves knowledge and management of acute myeloid leukemia

2021

Knowledge on acute myeloid leukemia pathogenesis and treatment has progressed recently, but not enough to provide ideal management. Improving the prognosis of acute myeloid leukemia patients depends on advances in molecular biology for the detection of new therapeutic targets and the production of effective drugs. The CRISPR/Cas9 technology allows gene insertions and deletions and it is the first step in investigating the function of their encoded proteins. Thus, new experimental models have been developed and progress has been made in understanding protein metabolism, antitumor activity, leukemic cell maintenance, differentiation, growth, apoptosis, and self-renewal, the combined pathogene…

TechnologyCD38acute myeloid leukemiamedicine.disease_causeGeneral Biochemistry Genetics and Molecular Biologycd38bcl2chemistry.chemical_compoundcrispr/cas9flt3 inhibitorshemic and lymphatic diseasesmedicineCRISPRHumansMidostaurinProtein Kinase InhibitorsCell ProliferationMutationCas9business.industryCell growthRMyeloid leukemiamedicine.diseaseidh2LeukemiaLeukemia Myeloid Acutechemistryfms-Like Tyrosine Kinase 3MutationCancer researchMedicineCRISPR-Cas SystemsbusinessBiomedical Papers
researchProduct

Murine liver organoids as a genetically flexible system to study liver cancer in vivo and in vitro.

2019

The rising incidence of cholangiocarcinoma (CCA) coupled with a low 5-year survival rate that remains below 10% delineates the urgent need for more effective treatment strategies. Although several recent studies provided detailed information on the genetic landscape of this fatal malignancy, versatile model systems to functionally dissect the immediate clinical relevance of the identified genetic alterations are still missing. To enhance our understanding of CCA pathophysiology and facilitate rapid functional annotation of putative CCA driver and tumor maintenance genes, we developed a tractable murine CCA model by combining the cyclization recombination (Cre)-lox system, RNA interference, …

TransplantationHepatologyCas9RNA interferencemedicineOrganoidCancer researchCRISPRContext (language use)BiologyLiver cancermedicine.diseasePhenotype
researchProduct

Mecanismos de resistencia a piretroides en ácaros depredadores

2023

Los piretroides constituyen un grupo de plaguicidas catalogados como moduladores del canal de sodio (Grupo 3), según el comité de acción contra la resistencia a los insecticidas (IRAC). Estos plaguicidas son análogos sintéticos de las piretrinas, compuestos naturales con actividad insecticida que se encuentran en las flores de las plantas del género Chrysanthemum, popularmente conocidas como crisantemos. Actualmente, existen numerosos productos plaguicidas que contienen en su formulación piretroides, siendo ampliamente utilizados en el control de plagas en diferentes contextos como la agricultura, la ganadería, la apicultura e incluso a nivel doméstico, erigiéndose como uno de los grupos de…

UNESCO::CIENCIAS DE LA VIDA::Genética ::Ingeniería genéticaCRISPRUNESCO::CIENCIAS DE LA VIDA::Biología de insectos (Entomología)::Entomología generalpiretroidesácaros depredadoresedición genómicaUNESCO::QUÍMICA::Bioquímica ::Biología molecularresistencia
researchProduct

Cooperation between Different CRISPR-Cas Types Enables Adaptation in an RNA-Targeting System

2021

CRISPR-Cas systems are immune systems that protect bacteria and archaea against their viruses, bacteriophages. Immunity is achieved through the acquisition of short DNA fragments from the viral invader’s genome.

bacteriophagesanimal diseasesvirusesevoluutiotype VIchemical and pharmacologic phenomenaadaptationFlavobacteriumMicrobiologybakteriofagitbakteeritClustered Regularly Interspaced Short Palindromic Repeatstype II1184 Genetics developmental biology physiologyDNAbiochemical phenomena metabolism and nutritionAdaptation PhysiologicalQR1-502immuunijärjestelmäCRISPRcoevolutionRNA ViralbacteriaRNAspacer acquisitionCRISPR-Cas Systemshorisontaalinen geeninsiirtoGenome BacterialResearch Article
researchProduct

Investigating REPAIRv2 as a Tool to Edit CFTR mRNA with Premature Stop Codons

2020

Cystic fibrosis (CF) is caused by mutations in the gene encoding the transmembrane conductance regulator (CFTR) protein. Some CF patients are compound heterozygous or homozygous for nonsense mutations in the CFTR gene. This implies the presence in the transcript of premature termination codons (PTCs) responsible for a truncated CFTR protein and a more severe form of the disease. Aminoglycoside and PTC124 derivatives have been used for the read-through of PTCs to restore the full-length CFTR protein. However, in a precision medicine framework, the CRISPR/dCas13b-based molecular tool &ldquo

congenital hereditary and neonatal diseases and abnormalitiesRNA editingMutantNonsense mutationSettore BIO/11 - Biologia MolecolareBiologyCRISPR/dCas13bCatalysislcsh:Chemistrycystic fibrosisInorganic ChemistryGuide RNASettore BIO/06 - Anatomia Comparata E CitologiaPhysical and Theoretical Chemistrylcsh:QH301-705.5Molecular BiologyGeneSpectroscopyMessenger RNApremature termination codons (PTCs)Organic ChemistryGeneral Medicinerespiratory systemStop codonTransmembrane proteinrespiratory tract diseasesComputer Science ApplicationsCell biologySettore BIO/18 - Geneticalcsh:Biology (General)lcsh:QD1-999RNA editingInternational Journal of Molecular Sciences
researchProduct

La rivoluzione dei semi senza sesso

2018

La tecnica di editing genetico CRISPR segna un altro importantissimo successo

editing genetico crisprSettore AGR/09 - Meccanica Agraria
researchProduct

Midbiotics : conjugative plasmids for genetic engineering of natural gut flora

2019

ABSTRACTThe possibility to modify gut bacterial flora has become an important goal, and various approaches are used to achieve desirable communities. However, the genetic engineering of existing microbes in the gut, which are already compatible with the rest of the community and host immune system, has not received much attention. Here, we discuss and experimentally evaluate the possibility to use modified and mobilizable CRISPR-Cas9-endocing plasmid as a tool to induce changes in bacterial communities. This plasmid system (briefly midbiotic) is delivered from bacterial vector into target bacteria via conjugation. Compared to, for example, bacteriophage-based applications, the benefits of c…

genetic engineeringantibiotic resistanceTRANSPLANTATIONsuolistomikrobistogeenitekniikkaTHERAPYplasmiditENTEROBACTERIACEAEconjugative plasmidNUCLEOTIDE-SEQUENCECARRIAGEGenetic engineeringRISK-FACTORSenterobakteeritESBL carriageCRISPR editing1183 Plant biology microbiology virologyenterobacteriaantibioottiresistenssi
researchProduct